Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 28Recruiting 12Active not recruiting 5Terminated 3Not yet recruiting 3Unknown 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Focus Groups × Clear all
NCT07520188 2026-05-19

CASCADE3002

UNC Lineberger Comprehensive Cancer Center

Not yet recruiting
3,500 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07105046 2026-03-02

Facilitators and Barriers to Cancer Treatment Among Texas Residents

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT07407686 2026-02-12

INCLUDE PC

Royal Marsden NHS Foundation Trust

Not yet recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡